Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Novo’s Haemophilia Drug Gets EU Approval

Summary by WTVB
Nov 13 (Reuters) – Novo Nordisk said on Friday the European Commission has granted approval for its treatment to prevent or ​reduce the frequency of bleeding episodes ‌in adults and children with haemophilia A, a rare blood disorder. Here are more details: • The drug, branded Frehemgo, is a next-generation antibody designed to mimic ‌the ​activity of the blood-clotting ⁠protein called factor VIII, ⁠according to Novo. It is administered as an und…

6 Articles

ReutersReuters
Reposted by
WTVBWTVB
Center

Novo's haemophilia drug gets EU approval

·London, United Kingdom
Read Full Article
berlingske.dkberlingske.dk
+2 Reposted by 2 other sources
Lean Right

Novo Receives European Approval to Sell Blood Thinner

Novo has received approval from the European Commission to sell the bleeding drug Frehemgo to patients with hemophilia A.

·Copenhagen, Denmark
Read Full Article
borsen.dkborsen.dk

Novo Receives EU Approval for New Drug Against Hemophilia

The EU Commission has approved Novo's drug frehemgo (denecimig) for the treatment of the bleeding disorder hemophilia A. Novo wrote this in a press release on Friday evening.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

avisendanmark.dk broke the news on Friday, November 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

European Commission icon

European Commission

Novo Nordisk icon

Novo Nordisk

European Union icon

European Union

Denmark icon

Denmark

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal